medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 6

<< Back Next >>

Med Int Mex 2020; 36 (6)

Use of the AST scale for alcohol withdrawal syndrome in Mexican population

Vázquez-Aguirre NA, Fonseca-González GT, García-Sánchez JL, Rivera-Rangel RM, Morales-Santaella AL, García-Minamy JI, Melchor-López A, Suárez-Cuenca JA

Language: Spanish
References: 20
Page: 774-780
PDF size: 201.56 Kb.


ABSTRACT

Background: The alcohol withdrawal syndrome may occur in several degrees of clinical severity, and specific treatment on it. There are many scales for staging the degree of severity. Currently, the scale Clinical Institute Withdrawal Assessment for Alcohol – reviewed (CIWA-Ar) is considered the gold standard to evaluate alcohol withdrawal. Despite its usefulness, the CIWA-Ar is constituted by several items, implying more time for the evaluator and broad subjectivity for the intervals of severity of a symptom. Anxiety, Sweating and Tremor Scale (AST) is a more summarized and useful scale for symptom assessment, in order to determine the severity of the alcohol withdrawal syndrome.
Objective: To evaluate the comparative performance of AST scale in Mexican patients with alcohol withdrawal syndrome.
Material and Method: Cross-sectional and analytical study done in patients with alcohol withdrawal syndrome from December 2017 to June 2018. A translation of the AST scale from English into Spanish was performed. The reliability of the instrument was evaluated.
Resultados: The AST scale was applied to 68 subjects with alcohol withdrawal syndrome, Cronbach’s alpha = 0.852 and a Cohen’s kappa concordance = 0.618 (p = 0.0001). A sensitivity of 84% and a specificity of 83.3% were obtained.
Conclusions: The AST scale is a useful instrument to determine the severity of the alcohol withdrawal syndrome in Mexicans.


REFERENCES

  1. Monteiro MG. Alcohol y salud pública en las Américas: un caso para la acción (Internet). Organización Panamericana de la Salud; 2007. Disponible en:www.who.int/substance_ abuse/publications/alcohol_public_health_americas_ spanish.pdf

  2. Substance Abuse and Mental Health Services Administration [Internet]. Substance Abuse Treatment Advisory Protracted Withdrawal. HHS Publication No. (SMA) 10-4554. 2010 Jul 9 (1). Available from: https://store.samhsa.gov/ system/files/sma10-4554.pdf

  3. Moore RD, Bone LR, Geller G, Mamon JA, Stokes EJ, Levine DM. Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA 1989; 261: 403-407.

  4. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974; 131: 1121-1123. doi: 10.1176/ajp.131.10.1121

  5. Hodgson R, Alwyn T, John B, Thom B, Smith A. The FAST alcohol screening test. Alcohol 2002; 37: 61-66.

  6. McKinley MG. Alcohol withdrawal syndrome overlooked and mismanaged? Crit Care Nurse 2005; 25: 40-42.

  7. Reoux JP, Malte CA, Kivlahan DR, Saxon AJ. The Alcohol Use Disorders Identification Test (AUDIT) predicts alcohol withdrawal symptoms during inpatient detoxification. J Addict Dis 2002; 21: 81-91. doi: 10.1300/J069v21n04_08

  8. Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med 2014; 371: 2109- 2113. doi: 10.1056/NEJMra1407298

  9. National Survey on Drug Use and Health [Internet]. Reports and detailed tables from the 2015 National Survey on Drug Use and Health (NSDUH); 2015. Disponible en: https:// www.samhsa.gov

  10. Schmidt KJ, Doshi MR, Holzhausen JM, Natavio A, Cadiz M, Winegardner JE. Treatment of severe alcohol withdrawal. Ann Pharmacother 2016; 50: 389-401. doi: 10.1177/1060028016629161

  11. Stehman CR, Mycyk MB. A rational approach to the treatment of alcohol withdrawal in the ED. Am J Emerg Med 2013;31:734-742. doi: 10.1016/j.ajem.2012.12.029

  12. Sarff M, Gold JA. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med 2010; 38 (9 Suppl): S494- S501. doi: 10.1097/CCM.0b013e3181ec5412

  13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. DSM-5. Washington, DC: American Psychiatric Publishing, 2013.

  14. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWAAr). Br J Addict 1989; 84: 1353-1357. doi: 10.1111/j.1360- 0443.1989.tb00737.x

  15. Wetterling T, Weber B, Depfenhart M, Schneider B, Junghanns K. Development of a rating scale to predict the severity of alcohol withdrawal syndrome. Alcohol Alcohol 2006; 41 (6): 611-615. doi: 10.1093/alcalc/agl068

  16. McPherson A, Benson G, Forrest EH. Appraisal of the Glasgow assessment and management of alcohol guideline: a comprehensive alcohol management protocol for use in general hospitals. QJM. 2012; 105: 649-656. doi: 10.1093/ qjmed/hcs020

  17. McPeake J, Bateson M, O’Neill A, Kinsella J. Assessment and management of alcohol-related admissions to UK intensive care units. Nurs Crit Care 2013; 18:187-192. doi: 10.1111/nicc.12006

  18. Hernández-Andraca K, Vargas-Ayala G, Cerda-Téllez F, Melchor- López A, Huerta-Ramírez S, Elizalde-Barrera CI. Validación de la escala CIWA en pacientes mexicanos con síndrome de supresión de alcohol. Med Int Mex 2012; 28 (2): 103-111.

  19. DeCarolis DD, Rice KL, Ho L, Willenbring ML, Cassaro S. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy 2007; 27: 510-518. doi: 10.1592/ phco.27.4.510

  20. Holzman SB, Rastegar DA. AST: A Simplified 3-item Tool for Managing Alcohol Withdrawal. J Addict Med 2016; 10 (3): 190-195. doi: 10.1097/ADM.0000000000000215




2020     |     www.medigraphic.com